Guardant Health logo

Guardant Health (GH) Q1 2026 Earnings

GH·Reported May 7, 2026·After market close

Guardant Health reported Q1 2026 revenue of $301.7M (+48.3% YoY), beat analyst consensus of $279.2M by $22.5M. Diluted EPS came in at $-0.85 (-73.5% YoY), missed the $-0.47 consensus by $0.38.

Revenue
$301.7Mbeat by $22.5M
Consensus: $279.2M
Diluted EPS
$-0.85missed by $0.38
Consensus: $-0.47
SEC

SEC Filings

Earnings release8-K · 0001576280-26-000024
Quarterly report10-Q · 0001576280-26-000026

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Guardant Health's Q1 2026 earnings report.

Guardant Health (GH) reported Q1 2026 earnings on May 7, 2026 after market close.

Guardant Health reported revenue of $301.7M and diluted EPS of $-0.85 for Q1 2026.

Revenue beat the consensus estimate of $279.2M by $22.5M. EPS missed the consensus estimate of $-0.47 by $0.38.

Compared to the same quarter a year prior, revenue grew 48.3% from $203.5M a year earlier and diluted EPS declined 73.5% from $-0.49.

You can read the 8-K earnings release (0001576280-26-000024) and the 10-Q periodic report (0001576280-26-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.